Home › Funds › ADAR1 Capital Management, LLC › TSHA

ADAR1 Capital Management, LLC position in TSHA

TAYSHA GENE THERAPIES INC · Health Care

ADAR1 Capital Management, LLC reported holding 3,040,466 shares of TSHA (TAYSHA GENE THERAPIES INC) in its Q2 2026 13F filing — a position valued at US$20.7M, representing 1.15% of its reported portfolio and ranking #19 among its reported holdings. ADAR1 Capital Management, LLC has disclosed TSHA holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)3.04M sh
Reported value held$20.71M
Portfolio Weight1.15%
First reportedQ4 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ADAR1 Capital Management, LLC's TSHA position evolved

ADAR1 Capital Management, LLC first disclosed a stake in TSHA in Q4 2023 at 209,000 shares (US$370K). The position peaked in Q2 2026 at 3,040,466 shares, worth US$20.7M. Across 11 filings, ADAR1 Capital Management, LLC increased the stake 5 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 3,040,466 shares valued at US$20.7M — an increase of 61,037 shares quarter over quarter.. Notable position changes include a 477% increase in Q2 2024 (shares fell 10% over the following quarter), a 500% increase in Q1 2025 (shares rose 66% over the following quarter), a 182% increase in Q2 2025 (shares rose 42% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 209.00K $369.93K New
Q1 2024 43.50K $124.84K Reduce
Q2 2024 250.80K $561.79K Add
Q3 2024 251.40K $505.31K Hold
Q4 2024 177.71K $307.43K Reduce
Q1 2025 1.07M $1.48M Add
Q2 2025 3.01M $6.95M Add
Q3 2025 2.84M $9.27M Reduce
Q4 2025 2.50M $13.73M Reduce
Q1 2026 2.98M $13.32M Add
Q2 2026 3.04M $20.71M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TSHA and 13F data

TSHA (TAYSHA GENE THERAPIES INC) is a Health Care company. 56 other funds we track also report a position in TSHA — the largest reported positions include Avoro Capital Advisors LLC (US$162.7M), RA CAPITAL MANAGEMENT, L.P. (US$160.4M), Vestal Point Capital, LP (US$132.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TSHA

All TSHA fund holders →

FAQ

How long has ADAR1 Capital Management, LLC held TSHA?

ADAR1 Capital Management, LLC has disclosed TSHA holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

What is ADAR1 Capital Management, LLC's current position in TSHA?

As of Q2 2026, ADAR1 Capital Management, LLC holds 3.04M shares of TSHA (TAYSHA GENE THERAPIES INC), valued at $20.71M, representing 1.15% of its reported portfolio and ranking #19.

Has ADAR1 Capital Management, LLC been buying or selling TSHA?

In the latest 13F filing (Q2 2026), ADAR1 Capital Management, LLC increased its position in TSHA. The position peaked in Q2 2026 at 3.04M shares.

Which other funds hold TSHA?

Other major institutional holders of TSHA include Avoro Capital Advisors LLC, RA CAPITAL MANAGEMENT, L.P., Vestal Point Capital, LP, among 56 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.